For instance, in a study by Nisancioglu et al., treatment of lung cancer in pericyte-deficient PDGF-B (ret/ret) mice with the anti–VEGFA antibody, G6-31, did not have any additional anti-tumor benefit (276). The gene discussed is VEGFA; the disease is neoplasm.